Disintegrins and venom proteinase inhibitors

Disintegrins and venom proteinase inhibitors refers to a broad group of bioactive proteins found in the venom of various snake species, particularly within the Viperidae and Elapidae families (UniProt, 2023). Disintegrins are small, cysteine-rich peptides that typically contain an RGD (Arg-Gly-Asp) or similar motif, which allows them to bind with high affinity to integrin receptors such as alpha-IIb/beta-3 on platelets (PubMed, PMID: 15561330). By binding to these receptors, they effectively inhibit platelet aggregation and disrupt normal hemostasis in the victim. Venom proteinase inhibitors, including Kunitz-type inhibitors, function by blocking the activity of serine proteases involved in the coagulation cascade or other physiological pathways (Journal of Biological Chemistry, 2011). While these molecules are primarily characterized as toxins that contribute to the pathology of snakebite envenomation, they have also served as important structural templates for the development of cardiovascular drugs like eptifibatide and tirofiban (StatPearls, 2023). In clinical practice, these proteins are the primary targets of antivenom therapies, such as Crotalidae Polyvalent Immune Fab, which utilize specific antibodies to neutralize their toxic effects (NIH, 2023). Neutralization prevents systemic complications such as hemorrhage and coagulopathy, while research also explores their potential in treating cancer metastasis due to their ability to inhibit cell-matrix interactions.

Other names

Snake venom disintegrinsKunitz-type venom proteinase inhibitorsVenom-derived integrin ligandsSnake venom toxins

Neutralization of toxin activity via antibody-mediated sequestration; competitive inhibition of integrin receptors; competitive inhibition of serine proteases